Provided by Tiger Trade Technology Pte. Ltd.

IMMUNOTECH-B

0.420
+0.0205.00%
Volume:69.00K
Turnover:27.87K
Market Cap:259.56M
PE:-0.86
High:0.445
Open:0.445
Low:0.380
Close:0.400
52wk High:5.400
52wk Low:0.330
Shares:618.00M
HK Float Shares:618.00M
Volume Ratio:0.76
T/O Rate:0.01%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.491
ROE:-242.61%
ROA:-20.57%
PB:-2.65
PE(LYR):-0.86
PS:- -

Loading ...

New National Essential Drug List Unveiled, Featuring First Major Inclusion of Innovative Drugs! Hong Kong Stock Connect Innovative Drug ETF (520880) Achieves Consecutive Weekly Gains, with Turnover of 42.83 Billion Yuan Reaching Second-Highest Historical Level

Deep News
·
Jul 12

Hong Kong Market Analysis: Capital Shifts from Tech to Biotech Amid Liquidity Drain and Sector Rotation

Stock News
·
Jul 10

Major Policy Update After 8 Years Fuels Broad Healthcare Rally; Hong Kong Connect Innovative Drug ETF Surges 4.38%

Deep News
·
Jul 10

Biomedical ETF Surges, Driven by New Drug List and CRO Order Recovery

Stock News
·
Jul 10

Donghai Securities: Pharmaceutical Sector Operations Continue to Stabilize, Innovative Drug Chain Remains Key Investment Focus

Stock News
·
Jul 10

Innovative Drugs Included in National Essential Medicines List for First Time; "Global Expansion + Policy" Dual Catalysts Drive Over 50% Increase in Huatai Bairui Hang Seng Innovation Drug ETF (520500) Shares Over Past Three Months

Deep News
·
Jul 10

New 2026 National Essential Medicines List Released, Sparking Surges in AH Healthcare Assets

Deep News
·
Jul 10

SIMCERE PHARMA Partners with Global AI Drug Design Leader Schrödinger, Leveraging Dual "Physics+AI" Tech to Reshape Innovative Drug Pipeline Valuation

Stock News
·
Jul 10

Major Indices Gain as Biotech and Tech Sectors Surge, with Hong Kong's Tech Index Up 2%

Deep News
·
Jul 10

Biotech Stocks Surge as New National Essential Drug List Includes Innovative Therapies

Stock News
·
Jul 10

Sun-Novo Pharma Committed to Strategic Positioning in Innovative Drug Development

Deep News
·
Jul 09

Domestic Innovative Drug Secures Another Major $1.9 Billion Out-Licensing Deal, Sparking Rebound in Hong Kong Connect Pharma Sector

Deep News
·
Jul 09

Navigating the Third Year of NewCo Model: Strategies for Sequoia China and Qiming Venture

Deep News
·
Jul 08

Is the Biotech Sector Rebounding? Fund Manager Sees Rotation and Short Covering as Catalysts

Deep News
·
Jul 08

China Claims 8 of Top 10 Global Pharma Deals; Huatai Bairui's Hang Seng Innovation Drug ETF (520500) Offers T+0 Trading for Rebound Opportunities

Deep News
·
Jul 08

Hong Kong Stock Connect Biotech Stocks Surge, Leading ETF Jumps Over 3% as Record-High Licensing Deals Signal a Paradigm Shift

Deep News
·
Jul 08

Zhaoke Ophthalmology-B's Innovative Presbyopia Treatment YUVEZZI™ Approved for Import and Use at Boao Super Hospital

Stock News
·
Jul 07

Is the Market Rotation Happening Again?

Deep News
·
Jul 06

Market Rotation Confirmed? Biotech Surges with Over 6% Gain for 520880! Agriculture, Livestock, and Fisheries Strengthen, High-Performing Brokerage Sector Attracts Capital! Tech Volatility May Present Allocation Window

Deep News
·
Jul 06

Understanding the Investment Rationale Behind China's Booming Biopharma Exports

Deep News
·
Jul 06